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Abstract
Background: Molecular spacing is important for cell adhesion in a number of ways, ranging from
the ordered arrangement of matrix polymers extracellularly, to steric hindrance of adhesion/
signaling complexes intracellularly. This has been demonstrated using nanopatterned RGD
peptides, a canonical extracellular matrix ligand for integrin interactions. Cell adhesion was greatly
reduced when the RGD-coated nanoparticles were separated by more than 60 nm, indicating a
sharp spacing-dependent threshold for this form of cell adhesion.
Results: Here we show a similar dependence of cell adhesion on the spacing of agrin, a protein
that exists as both a secreted, matrix-bound form and a type-2 transmembrane form in vivo. Agrin
was presented as a substrate for cell adhesion assays by anchoring recombinant protein to gold
nanoparticles that were arrayed at tunable distances onto glass coverslips. Cells adhered well to
nanopatterned agrin, and when presented as uniformly coated substrates, adhesion to agrin was
comparable to other well-studied adhesion molecules, including N-Cadherin. Adhesion of both
mouse primary cortical neurons and rat B35 neuroblastoma cells showed a spacing-dependent
threshold, with a sharp drop in adhesion when the space between agrin-coated nanoparticles
increased from 60 to 90 nm. In contrast, adhesion to N-Cadherin decreased gradually over the
entire range of distances tested (uniform, 30, 60, 90, and 160 nm). The spacing of the agrin
nanopattern also influenced cell motility, and peptide competition suggested adhesion was partially
integrin dependent. Finally, differences in cell adhesion to C-terminal agrin fragments of different
lengths were detected using nanopatterned substrates, and these differences were not evident
using uniformly coated substrates.
Conclusion:  These results suggest nanopatterned substrates may provide a physiological
presentation of adhesive substrates, and are consistent with cells adhering to agrin through a
mechanism that more closely resembles an interaction with the extracellular matrix than a
transmembrane adhesion molecule.
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Background
Proper cell adhesion is an important determinant for pro-
liferation, migration and differentiation. Adhesion is
often between ligands present in the extracellular matrix
(ECM) and cell-surface proteins such as integrins, provid-
ing cells an anchor point for morphogenetic changes.
Adhesion may also involve direct cell-cell contact via
other transmembrane or cell surface-associated proteins.
Cell-cell adhesion is particularly important in the nervous
system, where there is a paucity of laminin/collagen rich
matrix, but many sites of functional cell-cell interaction
that regulate cell migration, axon pathfinding, and syn-
apse formation and plasticity[1,2].
The proteoglycan agrin presents an interesting molecule
for studies of cell adhesion, particularly for neurons. Agrin
functions in neurodevelopment, and is an essential signal
for maintaining postsynaptic differentiation at the neu-
romuscular junction (NMJ) [3]. Agrin exists in multiple
protein isoforms, including a secreted, matrix-bound
form that is found at the NMJ and in other basement
membranes throughout the body, and a type 2 transmem-
brane form that is the predominant form expressed by
neurons of the central nervous system [4-6]. Thus, it can
be either a matrix-associated molecule, or a transmem-
brane, cell-associated molecule. It was our goal in these
studies to determine if cells, and especially neurons,
respond to agrin as they do to ECM ligands such as RGD
peptides, or as they do to transmembrane adhesion mol-
ecules such as cadherins.
In assays using recombinant agrin as an adhesive sub-
strate, the carboxy terminus of agrin was shown to medi-
ate neuronal adhesion. Some, but not all, of this adhesion
was dependent on Beta1 integrins, though a direct interac-
tion of agrin and integrins was not established [5]. Thus,
agrin may function as an ECM ligand for cell adhesion,
similar to the laminins, with which it binds. Alternatively,
the expression of the transmembrane form of agrin and
structural similarities with other transmembrane adhe-
sion molecules, such as neurexins, raise the possibility
that agrin also functions as a transmembrane adhesion
molecule in the nervous system [7]. The present study
uses nanopatterned surfaces to examine the properties of
cellular adhesion to molecularly defined agrin substrates,
and compares these to adhesion mediated by cadherins, a
well-established class of transmembrane, homophilic-
adhesion molecules, and to previous work on RGD pep-
tides, the canonical ECM ligand for integrin mediated
adhesion [8-10].
Nanopatterned substrates offer a number of advantages
for such studies. Gold nanoparticles can be deposited
onto slides and biofunctionalized with the protein of
interest, and the intervening space can be passivated with
polyethylene glycol (PEG) to prevent non-specific interac-
tions of the cell and substrate. Using this process, the sto-
ichiometry, orientation, and spacing of the protein being
presented as the adhesive substrate can be controlled. This
approach has been used to study the adhesion, spreading,
and motility of cells when presented with patterned RGD
peptides arrayed on 5 nm spots that should only interact
with single integrin complexes. This revealed a maximal
spacing between spots of 58 nm before integrin mediated
functions including adhesion, proliferation, and cell
spreading, decreased sharply [8-10].
The results of the present study indicate that the adhesion
profile of cells to patterned agrin more closely resembles
that of RGD peptides than cadherins, even for neuroblas-
toma cell lines and primary cortical neurons. This suggests
that cells recognize and adhere to agrin by mechanisms
that are more closely related to the mechanisms of adhe-
sion to the ECM than to transmembrane-protein-medi-
ated cell/cell adhesion.
Results
Adhesion of cells to nanopatterned agrin
In this study, agrin was used as a nanopatterned substrate
for cell adhesion assays. With this technique, gold nano-
particles 5–8 nm in diameter are arrayed on a glass slide
at tunable distances ranging from 30 to 160 nm between
particles (Figure 1A). The intervening glass surface is pas-
sivated with polyethylene glycol (PEG) to prevent adhe-
sion to areas other than the functionalized nanoparticles.
A construct consisting of the carboxy-terminal quarter (50
kDa) of rat agrin with C-terminal Myc and 6X-histidine
tags was expressed in Cos-7 cells and purified from the
media by nickel chromatography (C50) (Figure 1B). In
addition, a commercial agrin construct consisting of the
C-terminal half of agrin (100 kDa), with an N-terminal
histidine tag, was also used (C100) (Figure 1C). The nan-
oparticles were functionalized with these constructs using
a thiol-NTA linkage that reacts with the gold in the sub-
strate and the nickel bound by the histidine tag. Using this
approach, agrin is presented as a substrate for cell adhe-
sion with a controlled spacing, limited stoichiometry, and
fixed orientation. The validation and characterization of
agrin binding to the gold nanoparticles is described in
detail elsewhere [11-13].
Agrin is known to be a permissive substrate for cell adhe-
sion when presented in a uniform coating. The ability of
agrin to mediate cell adhesion when presented as a nano-
patterned substrate was tested using neuroblastoma cell
lines and agrin spaced at 60 nm. Cells were incubated on
the substrates for four hours, non-adherent cells were
washed off, and bound cells were quantified using a color-
imetric assay (see Methods). Both rat B35 cells and
human SHSY-5Y cells bound specifically to the agrin sub-BMC Cell Biology 2008, 9:64 http://www.biomedcentral.com/1471-2121/9/64
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strate (Figure 2). In this and subsequent experiments,
both C50 and C100 agrin constructs were used with simi-
lar results. The data shown is for C100 agrin unless other-
wise noted. No cell adhesion was seen on the PEG-
passivated portions of the slide that did not also have
agrin functionalized gold nanoparticles. Adherent cells
showed normal morphology, with a slightly elongated
soma and short processes. The "dipping edge" is also seen
in figure 2A, C (Arrows). This is a region of artifactually
high particle density that forms when the nanopatterned
Diagram of experimental system (A) Figure 1
Diagram of experimental system (A). Gold nanoparticles were deposited onto glass with spacing determined by the coat-
ing process. The nanoparticles are functionalized with different constructs of recombinant Agrin (or N-Cadherins) via NTA-
histidine interaction. The biofunctionalization and spacing between dots on the nanometer scale was varied, and the depend-
ence of cellular behaviour on these parameters was determined. B) Purification of Agrin analyzed by SDS-PAGE analysis and 
western blotting. C) Two carboxy-terminal agrin constructs (C100 and C50) were used in this study (SN – Short transmem-
brane N-terminus, LN- long, secreted N-terminus, F – follistatin repeat, GAG – glycosaminoglycan domain, SEA – Sea Urchin 
Sperm protein/enterokinase/agrin domain, ST – seronine/threonine rich region, EGF – EGF like repeat, G – laminin like globu-
lar domain, X, Y, Z sites of alternative splicing).
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surfaces are made using the dip-coating procedure (see
Methods). Therefore, cells efficiently adhere to agrin when
presented as a nanopatterned surface with 60 nm spacing.
Comparison of adhesive substrates
The goal of this study was to determine if adhesion to
agrin was more characteristic of adhesion to extracellular
matrix components, or to a cell surface adhesion mole-
cule. We therefore first compared agrin to other classes of
adhesion molecules using uniformly coated surfaces.
These other adhesive substrates included 1) laminin, an
extracellular matrix component, 2) L1, a Ig-superfamily
member transmembrane adhesion molecule, and 3,4) N-
cadherin and cadherin8, two classic homophilic cell sur-
face adhesion molecules. Both mouse C2C12 myoblasts
and human SHSY5Y neuroblastoma cells were tested with
similar results (Figure 3). C2C12 cells bound all substrates
significantly less efficiently than laminin (p values =
0.0002). However, adhesion to agrin was significantly
higher than adhesion to N-Cadherin or Cadherin8 (p =
0.004 and 0.0003 respectively). SHSY5Y cells bound agrin
and L1 without a significant reduction compared to lam-
inin. Binding to N-Cadherin and Cadherin8 was signifi-
cantly reduced relative to laminin (p = 0.0007 and 0.0002
respectively), but only Cadherin8 differed significantly
from agrin (p = 0.01). Three independent adhesion assays
were performed for each substrate and cell type, and adhe-
sion was standardized to the amount of adhesion
observed for laminin in each trial. Background binding on
BSA coated substrates was subtracted and all substrates
were deposited using 10 μg/ml solutions of recombinant
protein.
Agrin and N-Cadherin were next tested for their depend-
ence on spacing of the nanopattern. This provided a com-
parison of agrin to a homophilic adhesion molecule
where both provided good adhesion for a neuroblastoma
cell line. In each case, both primary mouse cortical neu-
rons and rat B35 neuroblastoma cells were tested (Figure
4). As above, results were obtained for three independent
assays and adhesion was standardized to uniformly
coated agrin or N-cadherin. For agrin, adhesion of both
primary cortical neurons and B35 cells was comparable to
uniformly coated protein at spacings of 30 and 60 nm
(Figure 4A, B). Primary cortical neurons did show a small
but significant reduction in adhesion to 60 nm spaced
agrin (p = 0.004), but the difference was not significant
compared to 30 nm spaced agrin (p = 0.8). However,
adhesion dropped significantly with 90 and 160 nm spac-
ing (p values = 0.0002). Adhesion to the 160 nm spaced
agrin was comparable to the negative control for both cell
types (p = 0.02 and 0.03). Negative controls were created
using BSA coated gold nanoparticles in the same PEG pas-
sivated environment.
The decreased agrin adhesion seen with increased spacing
may be an under-estimate. In more closely spaced pat-
Rat B35 neuroblastoma cells (A and B) and human SHSY-5Y  neuroblastoma cells (C and D) on C100-Agrin biofunctional- ized 60 nm substrates Figure 2
Rat B35 neuroblastoma cells (A and B) and human 
SHSY-5Y neuroblastoma cells (C and D) on C100-
Agrin biofunctionalized 60 nm substrates. Depicted is 
in A and C the dipping edge (arrows) and an overview of the 
cell population on biofunctionalized gold particles. Both cell 
types are able to build short cellular protrusions and the 
overall cell morphology is normal. Scale bars = 200 μm.
Static cell adhesion assays on uniformly coated substrates Figure 3
Static cell adhesion assays on uniformly coated sub-
strates. Different cell-cell adhesion molecules were used to 
evaluate cell adhesion of C2C12 mouse myoblasts (A) and 
SHSY-5Y human neuroblastoma cells (B). Values for adhesion 
to Laminin, a well-known component of cell matrix, were set 
to one relative unit. Agrin C100 functions as an adhesion 
molecule within the same range as Laminin, Cadherins, and 
Immunoglobulin superfamily members. Values are averages of 
three independent trial ± S.D.
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Cell adhesion on C100 Agrin nanopatterned substrates Figure 4
Cell adhesion on C100 Agrin nanopatterned substrates. Mouse primary cortical neurons (A) showed significantly 
higher adhesion to 30 nm and 60 nm spaced substrates than to 90 nm and 160 nm spaced substrates. Adhesion to more closely 
spaced substrates is comparable to homogenously coated agrin (first bar). Rat B35 neuroblastoma cells (B) showed a similar 
behaviour. Cell Adhesion on N-Cadherin nanopatterned substrates. Primary mouse cortical neurons (C) and Rat B35 neurob-
lastoma cells (D) do not show a significant decrease in cell adhesion with increasing spacing of the nanopatterned substrates, 
and adhesion is always below the level observed for uniformly coated N-Cadherin (first bar). This suggests a different mecha-
nism for N-Cadherin mediated cell adhesion than for Agrin mediated cell adhesion.
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terns, the cells were clearly adhering to the surface and
had normal morphologies. At 90 and 160 nm, the cells
were clumped, adhering to one another if one cell got pur-
chase on the substrate. This was true of both B35 cells and
primary neurons, with the primary cells clumping more
quickly than the neuroblastoma cells. Quantification of
this effect for the B35 cells is shown in Additional file 1.
This effect is probably mediated by classical cell-cell adhe-
sion mechanisms, although disrupting these mechanisms
through approaches such as the chelation of divalent cat-
ions decreases adhesion overall [5], making this assump-
tion difficult to test. Thus, as the values reported are based
on the number of adherent cells/sample, the number of
cells preferentially binding the substrate, as opposed to
binding other cells, may be even lower.
Unlike nanopatterned agrin, cell adhesion to N-cadherin
showed no sharp spacing-dependent threshold (Figure
4C, D). For both cell types (primary cortical neurons and
B35 cells), the adhesion to patterned substrates was signif-
icantly lower than to uniformly coated N-cadherin (p val-
ues from 0.005 to 0.0002). The amount of adhesion
decreased gradually as the spacing of the nanopattern
increased. No single step (30 to 60, 60 to 90, 90 to 160
nm) produced a significant decrease in adhesion, but all
patterned N-cadherin substrates showed adhesion signifi-
cantly above the negative control (p = 0.0002). Like cells
on patterned agrin, cell clumping was also observed on
the more widely spaced N-cadherin patterns. This again
suggests that the amount of adhesion on widely spaced N-
cadherin substrates may be an over-estimate, but unlike
agrin, these values were still significantly higher than neg-
ative controls. Therefore, adhesion to N-Cadherin is
dependent on spacing, but the relationship varies more
linearly with spacing and does not show a critical thresh-
old as agrin-mediated adhesion did.
Cell motility on nanopatterned agrin
The spacing of the nanopatterned agrin also influenced
cell motility (Figure 5), and this inversely correlated with
adhesion. Cells on more closely spaced patterns (30 and
60 nm) displayed less mobility than cells on more widely
spaced patterns (90, 160 nm). Interestingly, the mobility
differences were not purely a function of the cells' ability
to adhere, as cells on uniformly coated agrin or laminin
had intermediate motilities.
Motile cells often extend a leading process during migra-
tion; however, cell motility also inversely correlated with
the extension of processes, as assessed by a cell-spreading
index (see Additional file 2). On more closely spaced
agrin patterns, cells were flatter and extended short pro-
trusions. On more widely spaced agrin patterns, cells
extended fewer processes, had rounder cell bodies, and
occupied less surface area. Thus, strong cell adhesion to
closely spaced patterns led to the anticipated effects on
cell morphology and spreading, but the looser adhesion
of widely spaced patterns was more conducive to
increased cell motility.
Molecular mechanisms
The adhesion profile of cells on agrin nanopatterned
arrays (Figure 4) is very similar to the profile previously
reported for cells adhering to patterned RGD peptides,
where adhesion also dropped at > 60 nm spacing [8].
Since RGD is the canonical extracellular matrix ligand for
integrin-mediated cell adhesion [14], we tested the possi-
ble involvement of integrin signaling in adhesion to agrin
by adding competing peptides to cell adhesion assays
with 60 nm agrin spacing (Figure 6). The peptide IKVAV
(an active peptide found in the laminin alpha1 chain) sig-
nificantly reduced adhesion compared to control assays
performed with no competing peptide (p = 0.0002). This
effect was specific, and no decrease in adhesion was seen
Cell motility rates of B35 cells on different agrin C100 nano- patterned surfaces Figure 5
Cell motility rates of B35 cells on different agrin 
C100 nanopatterned surfaces. Single cells were evalu-
ated for 3 hours with live cell imaging with DIC optics. Cells 
appear to have lower motility rates on more closely spaced 
agrin C100 substrates. Interestingly, homogenously coated 
substrates show intermediate values.
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Peptide inhibition assay on 60 nm spaced C100 Agrin sub- strates Figure 6
Peptide inhibition assay on 60 nm spaced C100 Agrin 
substrates. The IKVAV peptide reduces B35 cell adhesion 
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using RGD or HAV (found in N-Cadherin) peptides com-
pared to the controls.
We also tested whether presenting agrin as a patterned ver-
sus unpatterned substrate influenced adhesion (Figure 7).
Indeed differences in cell adhesion were seen in compar-
ing the C-terminal 100 versus 50 kDa fragments when
each was patterned with 60 nm spacing, with C50 confer-
ring approximately half as much adhesion as C100 (p =
0.00002, ttest) (Figure 7A). However, consistent with pre-
vious studies, no differences were seen when these two
fragments were coated homogeneously (p = 0.6, ttest)
(Figure 7B). There are two possible explanations for this
difference. First, a mechanism for adhesion to C50 may be
functional when it is presented uniformly, but lost when
it is presented as a patterned substrate. However, this
mechanism would need to be retained in the C100 frag-
ment, even when it is nanopatterned. Alternatively, the
C50 and C100 constructs are presented in the reverse ori-
entation by virtue of their respective C-terminal and N-ter-
minal 6X His tags in the thiol-NTA functionalization of
the gold nanoparticles; whereas, they are presented in a
random orientation when homogeneously coated. In
either case, the differences detected by the patterned pres-
entation further suggest the usefulness of this approach
for assessing cellular responses to conditions that can be
controlled at the molecular scale.
Discussion
We have shown that agrin presented as a nanopatterned
substrate mediates adhesion for a variety of cell types,
including primary neurons and neuroblastoma cell lines.
In addition, we have shown that the dependence of adhe-
sion on the spacing of the agrin nanopattern has a sharp
spacing-dependent threshold, similar to that of the
canonical integrin ligand RGD, a component of many
ECM proteins [14]. In contrast, the cell-surface
homophilic adhesion molecule N-Cadherin has a more
linear dependence on spacing, with no significant spac-
ing-dependent threshold. Nanopatterned spacing also
influences cell motility and morphology, but not simply
in parallel with adhesion. Consistent with cells respond-
ing to agrin as they would to integrin-dependent extracel-
lular matrix ligands, adhesion was inhibited by
competing IKVAV peptides. Finally, nanopatterned sub-
strates are capable of highlighting differing cell responses
that are masked when the substrate is uniformly pre-
sented.
In addition to the effects on cell adhesion that we show,
cell proliferation had a similar dependence on the spacing
of agrin substrates (not shown). Both proliferation and
adhesion are often integrin-mediated processes, and the
inhibition of adhesion by the IKVAV peptide is consistent
with this. The IKVAV sequence was identified as an active
motif in the laminin alpha1 chain that promoted cell
adhesion, proliferation, and neurite extension, and these
effects depend, at least in part, on Beta1 integrins [15-17].
As such, the RGD and IKVAV peptides have been previ-
ously reported to be similarly effective [15]. Agrin con-
tains neither an RGD nor an IKVAV sequence; however,
previous studies have shown that adhesion of chick pri-
mary ciliary ganglion neurons to agrin was largely
dependent on Beta1 integrins, and was sensitive to RGD
peptide competition at a site that was also sensitive to
function blocking αV integrin antibodies. A second, non-
RGD-sensitive site of integrin-dependent cell-adhesion
mapped to a more C-terminal portion of agrin, although
both sites are contained within the C50 fragment [5]. The
insensitivity of rat B35 neuroblastoma cells to RGD pep-
tide competition in this study is interesting and may
reflect a greater dependence in this cell type for adhesion
to the more C-terminal domain of agrin. Together, these
results strongly suggest that adhesion to agrin is at least in
part integrin dependent, and the absence of an IKVAV or
RGD peptide may indicate that the interaction is either
indirect or mediated by a less-well defined domain.
Despite the lack of primary sequence homology, agrin
and laminins do share many structural similarities,
including EGF-like repeats and laminin-type globular
domains, found in the C-terminus of agrin.
Different B35 cell adhesion behaviour with different presen- tation of the Agrin C-terminal constructs Figure 7
Different B35 cell adhesion behaviour with different 
presentation of the Agrin C-terminal constructs. (A). 
On agrin substrates spaced at 60 nm, the C50 and C100 pro-
teins show a difference in cell adhesion. B) This effect is not 
seen using homogenously coated substrates, where cells 
adhere equally well to both constructs.
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The N-terminus of agrin and its heparan sulfate additions
have been extensively studied for their role in stopping
neurite outgrowth and promoting nerve terminal differ-
entiation [18,19]. Agrin has also been used in other bio-
physical studies in which its presentation was spatially
restricted either by using microcontact printing to pattern
substrates [20], or microfluidics to restrict the point of
agrin application [21,22]. These studies were designed to
investigate the spatial properties of agrin signaling in syn-
aptogenesis on muscle cells, an activity that maps to the
C-terminal portion of the protein, which is not subject to
glycosaminoglycan addition.
Since agrin exists as both a matrix protein and a trans-
membrane protein in vivo, we felt it was particularly
important to determine in which context cells are
responding to it [5,6]. The extracellular matrix bound iso-
form is the active form for neuromuscular junction synap-
togenesis [4]. However, agrin's role in the central nervous
system, where the transmembrane isoform predominates,
remains less clear. The loss of agrin effects synapse density
in the brain, and through interactions with the K-Na-
ATPase, is proposed to mediate activity dependent plastic-
ity [23,24]. Agrin also activates both C-Fos and CREB sig-
naling in neurons [25,26]. Given these disparate effects, it
is difficult to know what in vitro assays may most accu-
rately measure agrin's true function. We chose cell adhe-
sion as a first attempt to examine how neurons respond to
agrin, in part because this assay also allowed the compar-
ison to well-known components of the extracellular
matrix and to well-established transmembrane adhesion
molecules, such as L1 and cadherins. It is interesting that
even neurons respond to agrin more as cells respond to
the ECM ligand RGD than as they do to the transmem-
brane proteins N-cadherin.
Why is there a sharp threshold for adhesion to agrin and
RGD, but not N-cadherin? First, we have to acknowledge
that the comparison of agrin to one integrin-dependent
matrix ligand and one homophilic transmembrane adhe-
sion molecule is not exhaustive, but the consistencies and
inconsistencies are noteworthy. Our preferred explana-
tion is that adhesion to agrin requires an intracellular sig-
naling cascade, and the formation of an adhesion
complex analogous (if not identical) to that of integrin-
mediated adhesion to RGD. The size of these complexes
inside the cell may create a lower limit for spacing; pre-
sumably their effectiveness is reduced if the sites of adhe-
sion are spaced more closely than the diameter of such a
complex. This could explain the saturating effect seen at
30 and 60 nm spacing, which were similar to uniform
coating. The threshold for decreasing adhesion would
arise when the avidity of these complexes is no longer suf-
ficient to cause adhesion, not through the lack of signal at
an individual complex, but from the lack of sufficient
cumulative signal from the array of adhesive sites. In con-
trast, the N-cadherin mediated adhesion may be more
analogous to mechanical "Stickiness" at the cell surface,
where the force required to disrupt adhesion varies more
linearly with the protein's density on the membrane. The
absence of an intracellular cascade would eliminate the
threshold, and as long as some of the protein is present
there will be some amount of adhesion, with the upper
limit being defined at the molecular scale and by the affin-
ity of the interaction.
The affinity of the cellular receptors for the ligand may
also contribute to the agrin threshold effect. If this is the
case, it is interesting to note that integrins have a much
lower affinity for RGD peptides than for full-length
fibronectin [27], yet large agrin fragments have an appar-
ently similar threshold to RGD peptide. However, in con-
sidering affinity as an explanation, it is also important to
consider the constraints of our system. Each gold particle
is bound with only one or sometimes two proteins, and
this number should not change as the spacing changes
[13]. Therefore, at the molecular level, the number of lig-
ands presented to a cell-surface receptor is not changed; it
is the spacing between these sites of interaction this
changes. This effectively decreases the density of potential
attachment sites seen by a single cell by the square of the
change in spacing, but does not change the molecular
composition of an individual attachment site. Therefore,
avidity, and not classic receptor-ligand binding affinity, is
the variable. A biophysical test of this would be to meas-
ure the force of cell adhesion as the spacing of agrin and
N-cadherin is increased to confirm that our measures of
adhesion co-vary with mechanical force.
The subtleties of cellular responses to agrin, such as the
orientation of the protein, may have further implications
for function. For instance, the anti-parallel presentation
created by the N-terminal 6X His tag of C100 may more
closely resemble membrane-to-membrane interactions or
suggest an orientation of agrin within the meshwork of
matrix that is optimal for cellular recognition and bind-
ing.
In considering molecular spacing, laminin polymers in a
self-assembling meshwork form a polygon pattern with
vertices separated by 30–40 nanometers, comparable to
the 30–60 nanometer spacing of agrin-coated nanoparti-
cles that conferred optimal cell adhesion. Laminin polym-
erization also organizes other cell-surface proteins,
including dystroglycan, another receptor interacting with
the C-terminus of agrin [28-31]. Thus our results appear
to be in a physiologically relevant range of distances and
the patterning of ECM-associated ligands with such spac-
ing may actually provide a more physiological presenta-
tion. However, there are also limitations to the use ofBMC Cell Biology 2008, 9:64 http://www.biomedcentral.com/1471-2121/9/64
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nanopatterned substrates. For instance, if cell adhesion
depends on clustered adhesion molecules, the size of the
gold-nanoparticles as well as their spacing would be
expected to have a strong influence. Also, if adhesion
depends on a mix of proteins, either as homo-dimers or in
multiprotein complexes, the stoichiometric presentation
of the substrates would be more difficult to control.
An additional distinction between uniformly coated sub-
strates and the nanopatterned substrates such as we have
described is the thickness and rigidity of the substrate
itself. Homogeneous coating of glass with recombinant
proteins applied at 10 μg/ml results in a film of protein
that can be 100–200 nm thick (T. W. unpublished obser-
vations). However, molecules directly anchored to the
nanoparticles are presented in comparatively low copy
number and the thickness of the surrounding PEG-passi-
vation can be controlled by polymer length. Therefore, the
nanopatterned substrates are presumably more rigid and
more reproducible in their thickness and stiffness than
homogeneous substrates. Substrate rigidity has been
shown to have a variety of effects on cell morphology,
proliferation, and differentiation [32,33]. These effects
may also be influencing the cellular response to homoge-
neous versus patterned substrates, particularly for param-
eters like cell motility.
Conclusion
The results presented above are most consistent with cells
adhering to agrin through mechanisms that more closely
resemble interactions with the ECM and ligands such as
RGD, than with transmembrane adhesion molecules such
as N-Cadherin, which we tested in parallel. These findings
are of particular significance for agrin, which exists as both
a secreted, ECM-bound protein and as a type-2 transmem-
brane protein. We were most interested in examining the
adhesion properties of neurons, because the transmem-
brane form of agrin is the predominant isoform found in
the central nervous system, but its function there remains
unclear. Therefore, it is interesting that neurons recognize
agrin as though it was a matrix-presented ligand.
Future experiments can take advantage of the nanopat-
terned presentation of molecules such as agrin to address
additional questions of cell biology. For example, if agrin
is presented in the proper orientation with 30 nm spacing
in a grid 250 nm across, does it induce pre- or postsynap-
tic specializations in cultured neurons? Such a focal,
anchored presentation, which would approximate the
point of contact between an outgrowing axon and its post-
synaptic target, may cause very different effects than bath
application of soluble agrin in the media. Such an experi-
ment may bridge the apparent gap in agrin's central func-
tion in NMJ formation with its modest effects on synapse
formation in the central nervous system. The results pre-
sented here not only establish the feasibility of such stud-
ies, they also provide mechanistic suggestions for how
cells respond to agrin in comparison to other adhesion
molecules.
Methods
Recombinant Agrin and Cadherins
The recombinant C-terminal half of agrin was purchased
from R&D Systems (550-Ag) and includes amino acids
1153 to the end of the protein (1948), with a synthetic N-
terminal signal peptide for secretion and a 6X-histidine
tag for purification. This protein is herein referred to as
C100 agrin (C-terminal 100 kDa fragment). An expres-
sion construct for the C-terminal quarter of agrin (C-ter-
minal 50 kDa fragment, or C50) was generated using
following oligonucleotides for amplification from mouse
brain cDNA: 5'Agrin-BglII TAT AAG ATC TCC CTG CCA
GCC GAA CCC CTG and 3'Agrin-XhoI ATA TCT CGA
GAG TGG GGC AGG GTTC TTA G. Synthetic restriction
enzyme sites are in bold. The amplification product (1434
bp of agrin) was cloned into the BglII and XhoI sites of the
AP-5 Tag vector (Gene Hunter), which provides an in
frame N-terminal signal peptide for secretion and a C-ter-
minal myc-epitope tag and 6X histidine tag for purifica-
tion. The sequence of the cloned PCR product was
confirmed. This fragment is the equivalent of the previ-
ously reported human agrin fragment Δ 1480 [5].
Cadherin expression constructs were similarly prepared.
N-cadherin sequences were amplified from mouse brain
cDNA using the following primers: 5' ATATAGATCTGGT-
GAAATTGCATTATGCAAG and 3' ATATCTCGAG-
GCCCGTGCCAAGCCCTGCA. The amplified PCR
products were cloned into Topo II vectors (Invitrogen),
sequenced, and then cloned into the AP5 vector using
BglII and XhoI (bold sites). Cadherin8 was amplified
using 5' ATATGGCCCAGCCGGCCGCTCCGATGAAT-
CAGGCTCAC and 3' ATATGGGCCCCATACTGAGTC-
CAATAGGAAGG, cloned into TopoI, sequenced, and
moved into AP5 by SfiI and ApaI (bold) digestion and
ligation. In all cases, expression of full-length protein
products and purity were assessed by SDS-PAGE of recom-
binant protein purified by Nickel chromatography (Nova-
gen). All constructs were expressed in COS-7 cells using
Lipofectamine 2000 for the generation of recombinant
protein.
Generation of gold nanopatterned surfaces
Gold nanoparticle patterns from diblock copolymer
micelles were prepared on glass cover slips (Roth, Ger-
many) as previously described [8,34]. The molecular char-
acteristics of polystyrene-block-poly(2-vinylpyridine)
(PS-b-P2VP), diblock copolymer PS(500)-b-P2VP(270),
and diblock copolymer PS(990)-b-(385) were described
previously [8,11]. In brief, micellar suspensions areBMC Cell Biology 2008, 9:64 http://www.biomedcentral.com/1471-2121/9/64
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coated onto glass slides as monolayers. The organic com-
ponents of the micelles are then removed by heating in a
plasma oven and the gold nanoparticles are deposited
onto the glass. The spacing of the gold nanoparticles is
determined by the size of the organic compounds in the
micelles. Gold-free regions of the glass were passivated to
prevent unspecified protein attachment by immobilizing
linear polyethylene glycol (PEG, CH3-(O-CH2-CH2)17-
NH-CO-NH-CH2-CH2-CH2-Si(OEt)3) to the glass cover-
slips by first chemically activating the substrates (H2SO4/
H2O2 = 3:1) followed by substrate immersion in 1 mM
PEG solution in dry toluene (Merck, Germany) under
nitrogen atmosphere and incubation in oil bath at 80°C
for 24 hours [35]. Substrates were then rinsed extensively
with methanol and ethyl acetate (Aldrich, USA), blown
dry with nitrogen, and used directly for biofunctionaliza-
tion. Nanodot patterns were created with interspacings of
30 ± 4, 60 ± 8, 90 ± 11, and 160 ± 23 nm, and gold particle
diameters of 5 to 8 nm. The qquality of the gold nanopar-
ticle patterns was verified by scanning electron micros-
copy and atomic force microscopy.
Biofunctionalization of nanopatterned surfaces
Mono-thiol NTA was used to link gold nanoparticles to
the recombinant proteins. First, PEG-functionalized sub-
strates were immersed for 4 h in 1 mM mono-thiol NTA
in ethanol. Samples were washed with MilliQ-water, and
briefly incubated with 10 mM Ni2+ in HEPES buffered
saline (HBS). Following washes with phosphate-buffered
saline (PBS), the substrates were incubated with 1 μg/ml
6X-His tagged recombinant protein in PBS for the differ-
ent protein domains of agrin or cadherins over night at
4°C. Biofunctionalization was verified by immunofluo-
rescence staining and immunogold labeling as described
previously [12,13]. Immunogold labeling showed single
protein functionalization for most of the gold nanoparti-
cles.
Uniformly coated substrates were prepared by covering
O2-plasma activated cover slips with glutaraldehyde solu-
tion (2% in water) for 15 minutes at room temperature.
After washing, protein solutions at 10 μg/ml in PBS were
applied and incubated for 30 minutes before removing
the excess solution and rinsing.
Cell culture and adhesion assays
Neuroblastoma cells (B35 and SHSY5Y) were maintained
in DMEM supplemented with 10% fetal bovine serum
(FBS), and penicillin/streptomycin (PS) in a humidified
atmosphere containing 5% CO2  at 37°C. Myoblasts
(C2C12) were grown in DMEM supplemented with 20%
FBS and PS in 10% CO2 at 37°C. Primary cortical cultures
were prepared from dissociated neurons of embryonic day
15 C57BL/6J mouse embryos. Cortices were dissected
free, dissociated by a 12 minute incubation in trypsin in
HBSS, followed by tituration, and cultured in neuralbasal
media supplemented with B27 supplement (GIBCO) (2%
vol/vol), L-Glutamine (1%vol/vol), and penicillin/strep-
tomycin (PS).
Static adhesion assays were performed as described previ-
ously [36,37]. In brief, for homogeneously coated sub-
strates with Laminin, L1, N-Cadherin, Cadherin-8, and
Agrin (all 10 μg/ml in PBS) substrates were incubated
with 105 SHSY-5Y human neuroblastoma cells or C2C12
mouse myoblastoma cells. For nanopatterned Agrin or N-
Cadherin substrates, 30, 60, 90, and 160 nm substrates
were incubated with 105 B35 rat neuroblastoma cells or
106 primary cortical neurons per sample. Cells were cul-
tured for 4 hours at 37°C in starvation medium (1% FBS)
or neurobasal medium and rinsed three times with pre-
warmed PBS. To each sample 300 μl of substrate solution
with 3.75 mM p-nitropheno-N-acetyl-β-D-glucosaminide
(Sigma) in 50 mM citrate buffer was added and cells were
incubated at 37°C for 30 minutes. After incubation the
reaction was stopped by adding 450 μl of stop solution
containing 5 mM ethylene diamine tetra-acetic acid
(Sigma) in 50 mM glycine buffer. 150 μl of each sample
were transferred into a 96 well plate (Falcon) and the
absorbance at 405 nm was measured with a microplate
reader (Tecan). Relative cell adhesion was measured by
setting the homogeneously coated Agrin or N-Cadherin
control to 1 for each assay. All assays involved triplicate
trials with independently coated substrates, and the aver-
age of these was considered an n = 1. Each assay was
repeated minimally three times, and significance was
determined using One-Way Analysis of Variance
(ANOVA) unless otherwise noted, with p ≤ 0.01 consid-
ered significant.
For adhesion assays with peptide-inhibition, cells were
incubated with 100 μg/ml RGD peptide (Sigma), 100 μg/
ml IKVAV peptide (Sigma), or 1 mg/ml HAV peptide
(American Peptide). Cells were mixed in high-glucose
DMEM with the peptides and incubated for 30 min at 4°C
prior to plating on 60 nm spaced Agrin substrates. Cell
adhesion was assayed as described above.
Cell motility and cell spreading assays
Cells on their respective substrates were imaged for 3
hours using differential interference contrast (DIC) optics
on a Leica SP2 microscope with environmentally control-
led stage. Cells were maintained in starvation media with
1% FBS during these experiments. Images were obtained
every 10 minutes, and motility rates were determined
using ImageJ software. Three to five cells per field in 5 dif-
ferent samples per surface-type were analyzed. Cell motil-
ity was evaluated by analyzing the change in the location
of the center of each cell at 10 min intervals.BMC Cell Biology 2008, 9:64 http://www.biomedcentral.com/1471-2121/9/64
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The measurements of the cell area (cell surface) were ana-
lyzed after 6 hours incubation on each substrate. Cell
boundaries were marked in ImageJ, analyzed and com-
pared to the average of the cell surface area value obtained
on homogenously coated Agrin and Laminin substrates
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